Dr Andrew Sanders
Following graduation from Cardiff University I joined the then Metastasis and Angiogenesis Research Group to undertake a PhD studentship in prostate cancer, funded by Cancer Research Wales. After successfully attaining my PhD, I have continued to work within the Metastasis and Angiogenesis Research Group and the Cardiff China Medical Research Collaborative as a Research Fellow and Group Leader. My research focuses on Hepatocyte Growth Factor (HGF) signaling and the importance of the cytoskeletal associated protein Epithelial Protein Lost In Neoplasm (EPLIN) in cancer metastasis and assocaited therapeutic potentials. My current research focuses on the mechanisms involved in prostate and breast cancer cell homing to the bone environment.
I also have an interest in the biology of wound healing and its links with cancer, and I am involved in several projects exploring potential key factors in wound healing.
Education and qualifications
* 2004 – 2007; PhD in Cancer Biology, Cardiff University School of Medicine, Cardiff, UK
* 2000 – 2003; BSc in Applied Biology (1st class Hons), Cardiff University, Cardiff, UK
* Dec 2011 - Present: Research Associate/Fellow, Cardiff University. Research project exploring potential mechanisms responsible for the metastatic dissemination and predisposition of prostate cancer cells to the bone environment.
* May 2011 - Nov 2011: Research Associate, Cardiff University. Six month project characterising gene expression within clinical wound samples and potential diagnostic markers.
* May 2007 - May 2011: Research Associate, Cardiff University. Four year project to identify Hepatocyte Growth Factor (HGF) regulated gene expression and potential therapeutic implications of targeting these candidate genes.
* Oct 2004 – May 2007: PhD studentship, Cardiff University. Studentship exploring the potential of the Type II transmembrane serine protease family members, the matriptases, in prostate cancer metastasis.
Anrhydeddau a Dyfarniadau
* Travel award (WM Thomas Grant) to attend the European Cancer Conference (ECCO), Amsterdam, The Netherlands, 2017.
* Travel award (Morgan E Williams Grant), to attend the National Gastric Cancer Academic Conference (NGCAC) and the China-United Kingdom Cancer Conference 2014, Beijing, China 2014
* Travel award (William Morgan Thomas Grant), to attend the San Antonio Breast Cancer Symposium conference, San Antonio, USA 2011.
* British Prostate Group (BPG) scientific presentation prize, Cardiff, UK, 2006